- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
WISDOM Study Aims to Personalize Breast Cancer Screening
The study plans to evaluate the impact of a personalized approach to breast cancer screening over an annual mammogram.
Laura Esserman, professor in the Department of Surgery and Radiology at the UCSF Helen Diller Comprehensive Cancer Center has always been an out-of-the-box thinker. Now, as she leads the Athena Breast Health Network, they are ready to launch the WISDOM (Women Informed to Screen Depending on Measures of Risk) study, which will evaluate the impact of a personalized approach to breast cancer screening over an annual mammogram.
As October, the Breast Cancer Awareness Month, rolls in Dr Esserman lists some important information about breast cancer to improve women's understanding of the disease:
- Breast cancer isn't 1 disease
- Not all breast cancer is life threatening
- Not everyone needs the same approach to screening
- Consider participating in a clinical trial
- Precision medicine is promising.
"The essence of precision medicine is being able to tailor treatment to biology, patient preference and clinical performance," according to Esserman.
Read more here.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More
